IL10RA and inflammatory bowel disease: However, the impact of defective IL10 signaling on human intestinal inflammation has not been clarified (Glocker et al., 2009; Zheng et al., 2019) and little is known on risk factors associated with engraftment failure after the UCBT in IBD patients with IL10RA deficiency.